Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Circulation
|
October 20, 2004
Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction
Paul B Massion, Chantal Dessy, Fanny Desjardins, et al.
Circulation Research
|
December 24, 2005
H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart
Christophe Depre, Li Wang, Xiangzhen Sui, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 26, 2020
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities
Marie-Laure Ozoux, Véronique Briand, Michel Pelat, et al.
Circulation
|
November 10, 2004
Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice
Wim Verreth, Dieuwke De Keyzer, Michel Pelat, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 19, 2021
SAR340835, a Novel Selective Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart Failure
Michel Pelat, Fabrice Barbe, Cyril Daveu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Circulation
|
October 20, 2004
Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction
Paul B Massion, Chantal Dessy, Fanny Desjardins, et al.
Circulation Research
|
December 24, 2005
H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart
Christophe Depre, Li Wang, Xiangzhen Sui, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 26, 2020
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated Comorbidities
Marie-Laure Ozoux, Véronique Briand, Michel Pelat, et al.
Circulation
|
November 10, 2004
Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice
Wim Verreth, Dieuwke De Keyzer, Michel Pelat, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 19, 2021
SAR340835, a Novel Selective Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart Failure
Michel Pelat, Fabrice Barbe, Cyril Daveu, et al.
Page
of 2